Literature DB >> 11805007

Ultrarapid, ultrasensitive one-step kinetic immunoassay for C-reactive protein (CRP) in whole blood samples: measurement of the entire CRP concentration range with a single sample dilution.

Piia Tarkkinen1, Tom Palenius, Timo Lövgren.   

Abstract

BACKGROUND: Recently, measurement of very low concentrations of C-reactive protein (CRP) has gained popularity as a potential new means for predicting the risk of future cardiac complications. In this study, we demonstrate the feasibility of a kinetic, one-step microparticle assay for quantitative determination of extremely low and high CRP concentrations in the limited timeframe typical for point-of-care testing.
METHODS: A noncompetitive, kinetic CRP immunoassay was developed that uses individual, porous microparticles as the solid phase. The microparticles were covalently coated with a monoclonal capture antibody, and the monoclonal detection antibody was labeled with europium. The one-step binding reaction was stopped by washing after 2 min of incubation, and the fluorescence signal of individual particles was measured.
RESULTS: The analytical detection limit (mean of zero calibrator + 3 SD) was 0.00016 mg/L CRP. Clinical samples were diluted 400-fold before assay to cover the CRP concentration range of 0.064-1200 mg/L. The assay correlated well with the Dade Behring N High Sensitivity CRP assay (for 0-10 mg/L, r = 0.969, S(y/x) = 0.68, n = 54; for 0-350 mg/L, r = 0.969, S(y/x) = 11.7, n = 100). The within- and between-run CVs based on calculated concentrations were, respectively, 9-16% and 14% at 0.11 mg/L, 4.5-12% and 8.2% at 4.2 mg/L, and 3.5-6.3% and 4.4% at 105 mg/L, with a CV <15% at 0.2 mg/L and above.
CONCLUSIONS: Use of the kinetic microparticle approach combined with time-resolved fluorometry allows ultrasensitive quantification of CRP in whole blood in 2 min with a linear assay range spanning more than four orders of magnitude.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11805007

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  9 in total

1.  Plastic versus glass support for an immunoassay on metal-coated surfaces in optically dense samples utilizing directional surface plasmon-coupled emission.

Authors:  Evgenia G Matveeva; Ignacy Gryczynski; Joanna Malicka; Zygmunt Gryczynski; Ewa Goldys; Joseph Howe; Klaus W Berndt; Joseph R Lakowicz
Journal:  J Fluoresc       Date:  2005-11       Impact factor: 2.217

2.  Directional surface plasmon-coupled emission: application for an immunoassay in whole blood.

Authors:  Evgenia G Matveeva; Zygmunt Gryczynski; Joanna Malicka; Joanna Lukomska; Slawomir Makowiec; Klaus W Berndt; Joseph R Lakowicz; Ignacy Gryczynski
Journal:  Anal Biochem       Date:  2005-09-15       Impact factor: 3.365

3.  Validation of an assay for quantification of alpha-amylase in saliva of sheep.

Authors:  Maria Fuentes-Rubio; Francisco Fuentes; Julio Otal; Alberto Quiles; María Luisa Hevia
Journal:  Can J Vet Res       Date:  2016-07       Impact factor: 1.310

4.  Analytical and clinical validation of a time-resolved immunofluorometric assay (TR-IFMA) for canine C-reactive protein in serum.

Authors:  M D Parra; M Tuomola; J Cabezas-Herrera; J J Cerón
Journal:  Vet Res Commun       Date:  2006-02       Impact factor: 2.459

5.  Direct modulatory effect of C-reactive protein on primary human monocyte adhesion to human endothelial cells.

Authors:  K J Woollard; D C Phillips; H R Griffiths
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

6.  Absolute quantification of C-reactive protein in human plasma derived from patients with epithelial ovarian cancer utilizing protein cleavage isotope dilution mass spectrometry.

Authors:  D Keith Williams; David C Muddiman
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

Review 7.  Miniaturized technology for protein and nucleic acid point-of-care testing.

Authors:  Felix Olasagasti; Juan Carlos Ruiz de Gordoa
Journal:  Transl Res       Date:  2012-03-11       Impact factor: 7.012

8.  Obesity-related metabolic dysfunction in dogs: a comparison with human metabolic syndrome.

Authors:  Asta Tvarijonaviciute; Jose J Ceron; Shelley L Holden; Daniel J Cuthbertson; Vincent Biourge; Penelope J Morris; Alexander J German
Journal:  BMC Vet Res       Date:  2012-08-28       Impact factor: 2.741

9.  Hydrodynamic guiding for addressing subsets of immobilized cells and molecules in microfluidic systems.

Authors:  Thomas Brevig; Ulrich Krühne; Rachel A Kahn; Thomas Ahl; Michael Beyer; Lars H Pedersen
Journal:  BMC Biotechnol       Date:  2003-07-23       Impact factor: 2.563

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.